Cite
HARVARD Citation
Lee, T. et al. (2020). Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years. British journal of clinical pharmacology. 86 (5), pp. 852-860. [Online].